J&J's Alex Gorsky set to step away from CEO role, handing the reins to Covid-19 czar Joaquin Duato
Alex Gorsky, the CEO whose nine-year tenure at J&J was marred by lawsuits over the company’s talc baby powder and opioids, will step away from his role in January in favor of Joaquin Duato, the vice chairman of the executive committee and the man tasked with leading the company’s Covid-19 response.
Gorsky will take the executive chairman role on Jan. 3, J&J said in a release. In an interview with the Wall Street Journal, Gorsky said he was making the move due to “health issues.”
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 124,400+ biopharma pros reading Endpoints daily — and it's free.